Clinical Trials
Toshiba Corporation Advances Quantum Inspired Computing With 100 Fold Faster Optimisation Algorithm
Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprie...
April 08, 2026 | News
Amgen Reports Strong Phase 3 Results For Subcutaneous TEPEZZA In Thyroid Eye Disease
Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful R...
April 08, 2026 | News
Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development
Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...
April 07, 2026 | News
IDEAYA Biosciences Advances IDE574 Into Phase 1 As First Patient Enrolled For KAT6 And KAT7 Dual Inhibitor
Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low teens nano-molar cellular potency...
April 07, 2026 | News
Earendil Labs Advances HXN 1001 With First Patient Dosed In Phase IIa Ulcerative Colitis Trial
Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, announced the first patient has been dosed in a Phase IIa clin...
April 06, 2026 | News
Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer
- Collaboration with Amgen to explore the clinical potential of Zai Lab’s DLL3-targeting ADC, zocilurtatug pelitecan, in combination with Amge...
April 03, 2026 | News
CellCarta And Pillar Biosciences Partner To Accelerate NGS Tumor Profiling For Biomarker Driven Oncology Trials
CellCarta, a global provider of precision medicine laboratory services for drug development, and Pillar Biosciences, a leader in NGS-based oncology molecul...
April 03, 2026 | News
Gan And Lee Pharmaceuticals Reports Phase 3 Success For Once Weekly Insulin GZR4
Gan & Lee Pharmaceuticals announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 In...
April 02, 2026 | News
Abbisko Therapeutics Secures EMA Orphan Drug Status For Irpagratinib In Liver Cancer
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256) announced that its independently developed, highly selective, oral...
April 02, 2026 | News
Delonix Bioworks Initiates First In Human Trial Of DX 104 For Meningococcal B Vaccine
Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced the initiation of first-in-h...
April 01, 2026 | News
Hengrui Pharma And Braveheart Bio Report Strong Phase 2 Results For HRS 1893 In Obstructive Hypertrophic Cardiomyopathy
Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including s...
April 01, 2026 | News
Centivax Secures 37 Million Dollars In Oversubscribed Financing To Advance Universal Influenza Vaccine
Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets,...
April 01, 2026 | News
Anumana Secures FDA Clearance For AI Algorithm Enabling Early Detection Of Pulmonary Hypertension
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm...
March 30, 2026 | News
Takeda Reports Strong Phase 3 Results For Zasocitinib In Plaque Psoriasis
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A signifi...
March 30, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
